You can buy or sell AEMD and other stocks, options, ETFs, and crypto commission-free!
Aethlon Medical, Inc. Common Stock, also called Aethlon Medical, is a therapeutic technology company, which focuses on addressing global health and biodefense needs. Read More It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Yahoo FinanceMay 13
Aethlon Medical Announces Collaboration With Prostate On-Site Project, Host Of The Jerry Colangelo Sports Legend Golf Classic, To Engage With Participants For CTE Studies
Company also announces issuance of European patent covering TAUSOME™ technology PHOENIX, May 13, 2019 /PRNewswire/ -- Aethlon Medical Inc. (AEMD) and its diagnostic subsidiary, Exosome Sciences, in collaboration with the Translational Genomics Research Institute (TGen) and the Prostate On-Site Project (POP), announced that Aethlon, TGen and POP will engage with participants for their studies of chronic traumatic encephalopathy (CTE) in living individuals during the 18th annual Jerry Colangelo Sports Legend...
Expected Jun 7, After Hours